drugset / Trial / NCT04857827
A Study to Evaluate Safety and Tolerability of QLS-101 in NTG
RandomizedParallel-groupDouble-blindTreatment
Summary
A randomized active-controlled multi-site double-masked 28 day study to evaluate the safety and tolerability of QLS-101 versus timolol maleate Preservative Free (PF) 0.5% ophthalmic solution in subjects with normal tension glaucoma
Timeline
- Start
- 2021-09-15
- Primary completion
- 2022-08-26
- Completion
- 2022-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QLS-101 | Unknown | 1 % | Other |
| Subject | QLS-101 | Unknown | 2 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |